Document is current

Article History

Accepted: 24 December 2020

First Online: 25 January 2021

Declarations

:

: This study was sponsored by Novartis Pharma AG.

: Ronan Mahon, Andrea Lang, Jasper Huels, Philip Cooney, Andriy Danyliv, Umakanth Vudumula, Sreelatha Vadapalle and Pamela Vo are employees of Novartis. Peter J. Goadsby has received personal fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Biohaven Pharmaceuticals Inc., Clexio, Electrocore LLC, eNeura Inc, Impel Neuropharma, MundiPharma, Novartis, Teva Pharmaceuticals and WL Gore; grants and personal fees from Amgen and Eli Lilly and Company; a grant from Celgene; and other funding from Trigemina, all outside the submitted work; has a patent magnetic stimulation for headache licensed to eNeura without fee; and has received fees for publishing from Oxford University Press, Massachusetts Medical Society, Wolters Kluwer and fees for medico-legal work. Farooq Maniyar has received personal fees from Novartis for attending advisory board meetings, key opinion leader meetings and delivering lectures.

: The data that support the findings of this study are available from the corresponding author upon reasonable request.

: Not applicable.

: All named authors meet the International Committee of Medical Journal Editors criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for this version to be published.

: The authors gratefully acknowledge David Campbell of Xcenda for his editorial contributions to this work.

: Not applicable.

: Not applicable.

: Not applicable.